Chromosomal basis of adenocarcinoma of the prostate

Cancer Investigation

Volumn 17, Issue 6, 1999, Pages 441-447

  Verma, Ram S ^a,b,c,e   Manikal, Monali ^d   Conte, Robert A ^d   Godec, Ciril J ^d  

^a WYCKOFF HEIGHTS MEDICAL CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c SUNY DOWNSTATE MEDICAL CENTER   (United States)

^d LONG ISLAND COLLEGE HOSPITAL   (United States)

^e Inst of Molec Biology and Genetics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR;

ARTICLE; CHROMOSOME 1Q; CHROMOSOME ABERRATION; CYTOGENETICS; DISEASE COURSE; GENETIC ANALYSIS; GENETIC RISK; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; RECEPTOR GENE; SOUTHERN BLOTTING;

EID: 0032767783     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.3109/07357909909021436     Document Type: Article

References (124)

1. Karp JE, Chiardo A, Brawley O, et al: Prostate cancer prevention: investigational approaches and opportunities. Cancer Res 56:5547-5556, 1996.
2. Parker SL, Tong T, Bolden S, et al: Cancer statistics. CA Cancer J Clin 47:5-27, 1997.
3. Isaacs WB, Bove GS: Prostate cancer. In: The Genetic Basis of Human Cancer, edited by B Vogelstein, KW Kinzler, New York, McGraw-Hill, 1998, pp. 653-660.
4. Gleason DF: Histologic grading of prostate cancer. A perspective [review]. Hum Pathol 23:273-279, 1993.
5. Montie JE: 1992 Staging system for the prostate cancer [review]. Semin Urol 11:10-13, 1993.
6. Oesterling JE: Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate [review]. J Urol 145:907-923, 1991.
7. Lundgren R, Kristoffersson U, Heim S, et al: Multiple structural chromosome rearrangements, including del (7q) and del (10q) in an adenocarcinoma of the prostate. Cancer Genet Cytogenet 35:103-108, 1988.
8. Babu VR, Miles BJ, Cerny JC, et al: Cytogenetic study of four cancers of the prostate. Cancer Genet Cytogenet 48:83-87, 1990.
9. Brothman AR, Peehl DM, Patel AM, et al: Frequency and pattern of karyotyping abnormalities in human prostate cancer. Cancer Res 50:3795-3803, 1990.
10. Lundgren R, Mandahl N, Heim S, et al: Cytogenetic analysis of 57 primary prostate adenocarcinomas. Genes Chromosomes Cancer 4:16-24, 1992.
11. Micale MA, Mohamed A, Sakr W, et al: Cytogenetics of primary prostatic adenocarcinoma: clonality and instability. Cancer Genet Cytogenet 61:165-173, 1992.
12. Arps S, Rodewald A, Schmalenberger B, et al: Cytogenetic survey of the prostate. Cancer Genet Cytogenet 66:93-99, 1993.
13. Casalone R, Portentoso P, Granata P, et al: Chromosome changes in benign prostatic hyperplasia and their significance in the origin of prostatic carcinoma. Cancer Genet Cytogenet 66: 126-130, 1993.
14. Micale MA, Sanford JS, Powell IJ, et al: Defining the extent and nature of cytogenetic events in prostatic adenocarcinoma: paraffin FISH vs metaphase analysis. Cancer Genet Cytogenet 69:7-12, 1993.
15. Milasin J, Micic S: Double minute chromosomes in an invasive adenocarcinoma of the prostate. Cancer Genet Cytogenet 72: 157-159, 1994.
16. Webb HD, Hawkins AL, Griffin CA: Cytogenetic abnormalities are frequent in uncultured prostate cancer cells. Cancer Genet Cytogenet 88:126-132, 1996.
17. Zitzelsberger H, Szücs S, Robens E, et al: Combined cytogenetic and molecular genetic analyses of fifty-nine untreated human prostate carcinoma. Cancer Genet Cytogenet 90:37-44, 1996.
18. Smith JR, Freije D, Carpten JD, et al: Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science 274:1371-1374, 1996.
19. Alcaraz A, Takahashi S, Brown JA, et al: Aneuploidy and aneusomy of chromosome 7 detected by fluorescence in-situ hybridization are markers of poor prognosis in prostate cancer. Cancer Res 54:3998-4002, 1994.
20. Bandyk MG, Zhao L, Troncoso P, et al: Trisomy 7: a potential cytogenetic marker of human prostate cancer progression. Genes Chromosomes Cancer 9:19-27, 1994.
21. Takahashi S, Shan AL, Ritland R, et al: Loss of heterozygosity at 7q31.1 in primary prostate cancer is associated with tumor aggressiveness and progression. Cancer Res 55:4114-4119, 1995.
22. Emmert-Buck MR, Vocke CD, Pozzatti RO, et al: Allelic loss on chromosome 8p12-21 in microdissected prostatic interepithelial neoplasia. Cancer Res 55:2959-2962, 1995.
23. Bova GS, Carter BS, Bussemakers MJ, et al: Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer. Cancer Res 53:3869-3873, 1993.
24. Vocke CD, Pozzatti RO, Bostwick DG, et al: Analysis of 99 microdissected prostate carcinomas reveals a high frequency of allelic loss on chromosome 8p12-21. Cancer Res 56:2411-2416, 1996.
25. Macoska JA, Trybus TM, Benson PD, et al: Evidence for three tumor suppressor gene loci on chromosome 8p in human prostate cancer. Cancer Res 55:5390-5395, 1995.
26. Gray IC, Phillips SM, Lee SJ, et al: Loss of the chromosomal region 10q23-25 in prostatic cancer. Cancer Res 55:4800-4803, 1995.
27. Atkin NB, Baker MC: Chromosome study of five cancers of the prostate. Hum Genet 70:359-364, 1985.
28. Carter BS, Ewing CM, Ward WS, et al: Allelic loss of chromosomes 16q and 10q in human prostate cancer. Proc Natl Acad Sci USA 87:8751-8755, 1990.
29. Alers JC, Krijtenburg PJ, Vissers KJ, et al: Interphase cytogenetics of prostate adenocarcinoma and precursor lesions: analysis of 25 radical prostatectomies and 17 adjacent prostatic intraepithelial neoplasias. Genes Chromosomes Cancer 12:241-250, 1995.
30. Brothman AR, Patel AM, Peehl DM, et al: Analysis of prostatic tumor cultures using fluorescence in-situ hybridization (FISH). Cancer Genet Cytogenet 62:180-185, 1995.
31. Cher ML, Ito T, Widner N, et al: Mapping of regions of physical deletion on chromosome 16q in prostate cancer cells by fluorescence in-situ hybridization (FISH). J Urol 153:249-254, 1995.
32. Takahashi S, Alcaraz A, Brown JA, et al: Aneusomies of chromosomes 8 and Y detected by fluorescence in situ hybridization are prognostic markers for pathological stage C (PT3NoMo) prostate carcinoma. Clin Cancer Res 2:137-145, 1996.
33. Takahashi S, Qian J, Brown JA, et al: Potential markers of prostate cancer aggressiveness detected by fluorescence in-situ hybridization in needle biopsies. Cancer Res 54:3574-3579, 1994.
34. Brothman AR, Watson MJ, Watson X, et al: Evaluation of 20 archival prostate tumor specimens by fluorescence in-situ hybridization (FISH). Cancer Genet Cytogenet 75:40-44, 1994.
35. Cooney KA, Wetzel JC, Consolino CM, et al: Identification and characterization of proximal 6q deletions in prostate cancer. Cancer Res 56:4150-4153, 1996.
36. Visakorpi T, Kallioniemi AH, Syvanen AC, et al: Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. Cancer Res 55:142-147, 1995.
37. Isaacs WB: Molecular genetics of prostate cancer. In: Genetics and Cancer: A Second Look, edited by BA Ponder, WK Cavenee, E Solomon, Plainview, New York, Cold Spring Harbor Laboratory Press, 1995, pp. 357-380.
38. Jenkins RB, Qian J, Lieber MM, et al: Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization. Cancer Res 57:524-531, 1997.
39. Breitkreuz T, Romanakis K, Lutz S, et al: Genotype characterization of prostatic carcinomas: a combined cytogenetic, flow cytometry and in situ DNA hybridization study. Cancer Res 3: 4035-4040, 1993.
40. Brothman AR, Peehl DM, Patel AM et al: Cytogenetic evaluation of 20 cultured primary prostatic tumors. Cancer Genet Cytogenet 55:79-84, 1991.
41. Debruyne FMJ, Collins VP, van Dekken H et al: Cytogenetics of prostate cancer. Scand J Urol Nephrol Suppl 162:65-71, 1994.
42. Gibas Z, Pontes JE, Sandberg AA: Chromosomal rearrangements in a metastatic adenocarcinoma of the prostate. Cancer Genet Cytogenet 16:301-304, 1985.
43. Henke R-P, Kruger E, Ayhan N, et al: Frequency and distribution of numerical chromosomal aberrations in prostatic cancer. Hum Pathol 25:476-484, 1994.
44. Jones E, Zhu XL, Rohr LR, et al: Aneusomy of chromosomes 7 and 17 detected by FISH in prostate cancer and the effect of selection in vitro. Genes Chromosomes Cancer 11:163-170, 1994.
45. Lundgren R, Heim S, Mandahl N, et al: Chromosome abnormalities are associated with unfavorable outcome in prostatic cancer patients. J Urol 147:784-788, 1992.
46. Macoska JA, Trybus TM, Sakr WA, et al: Fluorescence in situ hybridization analysis of 8p allelic loss and chromosome 8 instability in human prostate cancer. Cancer Res 54:3824-3830, 1994.
47. Oshimura M, Sandberg AA: Isochromosome 17 in prostatic cancer. J Urol 114:249-250, 1975.
48. Sandberg AA: Chromosomal abnormalities and related events in prostate cancer. Hum Pathol 23:368-380, 1992
49. Konig JJ, Teubel W, van Dongen JW, et al: Tissue culture loss of aneuploid cells from carcinoma of the prostate. Genes Chromosomes Cancer 8: 22-27, 1993.
50. Eagle LR, Yin X, Brothman AR, et al: Mutation of the MXII gene in prostate cancer. Nat Genet 9:249-255, 1995.
51. Bergerheim USR, Kunimi K, Collins VP, et al: Deletion mapping of chromosomes 8, 10, and 16 in human prostatic carcinoma. Genes Chromosomes Cancer 3:215-220, 1991.
52. Brothman AR, Steel MR, Williams BJ, et al: Loss of chromosome 17 loci in prostate cancer detected by polymerase chain reaction quantitation of allelic markers. Genes Chromosomes Cancer 13:278-284, 1995.
53. Latil A, Baron J-C, Cussenot O, et al: Genetic alterations in localized prostate cancer: identification of a common region of deletion on chromosome arm 18q. Genes Chromosomes Cancer 11:119-125, 1994.
54. MacGrogan D, Levy A, Bostwick D, et al: Loss of chromosome arm 8p loci in prostate cancer: mapping by quantitative allelic imbalance. Genes Chromosomes Cancer 10: 151-159, 1994.
55. Macosa JA, Powell IJ, Sakr W, et al: Loss of the 17p chromosomal region in a metastatic carcinoma of the prostate. J Urol 147:1142-1146, 1992.
56. Macosa JA, Micale MA, Sakr WA, et al: Extensive genetic alterations in prostate cancer revealed by dual PCR and FISH analysis. Genes Chromosomes Cancer 8:88-97, 1993.
57. Phillips SMA, Morton DG, Lee SJ, et al: Loss of heterozygosity of the retinoblastoma and adenomatous polyposis susceptibility gene loci and in chromosomes 10p, 10q and 16q in human prostate cancer. Br J Urol 73:390-395, 1994.
58. Zenklusen JC, Thompson JC, Troncoso P, et al: Loss of heterozygosity in human primary prostate carcinoma: a possible tumor suppressor gene at 7q31.1. Cancer Res 54:6370-6373, 1995.
59. Baretton GB, Valina C, Vogt T, et al: Interphase cytogenetic analysis of prostatic carcinomas by use of nonisotopic in situ hybridization. Cancer Res 54:4472-4480, 1994.
60. Brown JA, Alcaraz A, Takahashi S, et al: Chromosomal aneusomies detected by fluorescent in situ hybridization analysis in clinically localized prostate carcinoma. J Urol 152:1157-1162, 1994.
61. Matsuyama H, Pan Y, Skoog L, et al: Deletion mapping of 8p in prostate cancer by fluorescence in situ hybridization. Oncogene 9:3071-3076, 1994.
62. Person DL, Gibney DJ, Katzmann JA, et al: Use in situ hybridization for deoxyribonucleic acid ploidy analysis of prostatic adenocarcinoma. J Urol 150:120-125, 1993.
63. Visakorpi T, Hyytinen E, Kallioniemi A, et al: Sensitive detection of chromosome copy number aberrations in prostate cancer by fluorescence in situ hybridization. Am J Pathol 145:624-630, 1994.
64. Williams BJ, Jones E, Brothman AR: Homozygous centromere association of chromosomes 9 and 17 in prostate cancer. Cancer Genet Cytogenet 85:143-152, 1995.
65. Zitzelberger H, Szucs S, Weier H-U, et al: Numerical abnormalities of chromosome 7 in human prostate cancer detected by fluorescence in situ hybridization (FISH) on paraffin embedded tissue with centromere-specific DNA probes. J Pathol 172:325-335, 1994.
66. Cher ML, MacGrogan D, Bookstein R, et al: Comparative genomic hybridization, allelic imbalance and fluorescence hybridization on chromosome 8 in prostate cancer. Gene Chromosome Cancer 11:153-162, 1994.
67. Rinker-Schaeffer CW, Hawins AL, Ru N, et al: Differential suppression of mammary and prostate cancer metastasis by human chromosomes 17 and 11. Cancer Res 54:6249-6256, 1994.
68. Trapman J, Sleddens HF, van der Weiden, et al: Loss of heterozygosity of chromosome 8 microsatellite loci implicates a candidate tumor suppressor gene between the loci D8S113 in human prostate cancer. Cancer Res 54: 6061-6064, 1994.
69. Suzuki H, Emi M, Komiya A, et al: Localization of tumor suppressor gene associated with progression of human prostate cancer within a 1.2 Mb region of 8p22-p21.3. Genes Chromosomes Cancer 13: 168-174 , 1995.
70. Emmert-Buck MR, Vocke CD, Pozzatti RO, et al: Allelic loss on chromosome 8p12-21 in microdissected prostate intraepithelial neoplasia. Curr Res 55:2959-2962, 1995.
71. Bova GS, MacGrogan D, Levy A, et al: Physical mapping of chromosome 8p22 markers and their homozygous deletion in metastatic prostate cancer. Genomics 35:46-54, 1996.
72. Konig JJ, Kamst E, Hagemeijer A, et al: Cytogenetic characterization of several androgen responsive and unresponsive sublines of the human prostatic carcinoma cell line LNCaP. Urol Res 17: 79, 1989.
73. Joos S, Bergerheim USR, Pan Y, et al: Mapping of chromosomal gain and losses in prostate cancer by comparative genomic hybridization. Genes Chromosomes Cancer 14:267-276, 1995.
74. Cher ML, Bova GS, Moore DH, et al: Genetic alteration in untreated prostate cancer metastases and androgen independent prostate cancer detected by comparative genomic hybridization and allotyping. Cancer Res 56:3091-3102, 1996.
75. Van den Berg C, Guan XY, Van Hoff D, et al: DNA sequence amplification in human prostate cancer identified by chromosome microdissection: Potential prognostic implication. Clin Cancer Res 1:11-14, 1995.
76. Watson DL, Mashal R, Krithivas K, et al: Loss of heterozygosity at chromosome locus 7q21-q31 in metastatic prostate cancer. 153:153-271, 1995.
77. Ittman M: Allelic loss on chromosome 10 in prostate adenocarcinoma. Cancer Res 55:4800, 1995.
78. Williams BJ, Jones E, Zhu XL, et al: Evidence for the tumor suppressor gene distal to BRCA1 prostate cancer. J Urol 155: 720-725, 1996.
79. Williams BJ, Jones E, Kozlowsky JM, et al: Comparative genomic hybridization and molecular cytogenetic characterization of two prostate cancer xenografts. Genes Chromosomes Cancer 18: 299-304, 1997.
80. Osman I, Sher H, Dalvagni G, et al: Chromosome 16 in primary prostate cancer: a microsatellite analysis. Int J Cancer 71:580-584, 1997.
81. Dong J-T, Lamb PW, Rinker-Schaeffer CW, et al: KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science 268:884-886, 1995.
82. Henke RP, Kruger E, Ayhan N, et al: Numerical chromosomal aberrations in prostate cancer: correlation with morphology and cell kinetics. Virchows Arch A Pathol Anat Histopathol 422:61-66, 1993.
83. Konig JJ, Teubel W, van Dongen JW, et al: Loss and gain of chromosomes 1, 18 and Y in prostate cancer. Prostate 25:281-291, 1991.
84. Lundgren R: Cytogenetic studies of prostatic cancer. Scand J Urol Suppl 136:1-35, 1991.
85. Qian J, Bostwick D, Takahashi DS, et al: Chromosomal anomalies in prostatic interepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization. Cancer Res 55:5408-5414, 1995.
86. Komiya A, Suzuki H, Ueda T, et al: Allelic losses at loci on chromosome 10 are associated with metastasis and progression of human prostate cancer. Genes Chromosomes Cancer 17:245-253, 1996.
87. Konig JJ, Teubel W, Komst E, et al: Cytogenetic analysis of 39 prostate carcinomas and evaluation of short term tissue culture techniques. Cancer Genet Cytogenet 101:116-122, 1998.
88. Qi H, Dal-Cin P, van de Voorde W, et al: del(1)(q12) in adenocarcinoma of the prostate. Cancer Genet Cytogenet 87:79-81, 1996.
89. Azar GM, DiPillo F, Gogineni SK, et al: Highly complex chromosomal aberrations in bone marrow of a patient with metastatic prostate neoplasm. Cancer Genet Cytogenet 99: 116-120, 1997.
90. Koivisto PA: Molecular cytogenetics of prostate cancer. Crit Rev Oncogen 7:143-150, 1996.
91. Brothman AR: Prostate cancer: molecular and cellular abnormalities. In: Molecular Biology of Cancer, Vol. II, edited by JR Bertino, New York, Academic Press, 1996, pp. 1303-1313.
92. Brothman AR, Williams BJ: Prostate cancer. In: Cytogenetic Markers of Human Cancer, edited by S Wolman, S Sell, Totowa, NJ, Humana Press, 1997, pp. 223-246.
93. Brothman AR: Cytogenetic studies in prostate cancer: are we making progress. Cancer Genet Cytogenet 95:116-121, 1997.
94. Jenkins RB, Qian J, Lee HK, et al: A molecular cytogenetic analysis of 7q31 in prostate cancer. Cancer Res 58:759-766, 1998.
95. Collard JG, van de Poll, Scheffer A, et al: Location of genes involved in invasive and metastasis on human chromosome 7. Cancer Res 47:6666-6670, 1987.
96. Cheng L, Shan A, Cheville JC, et al: Atypical adenomatous hyperplasia of the prostate: a premalignant lesion. Cancer Res 58: 389-391, 1998.
97. Bostwick DG, Pacelli A, Lopez-Beltran A: Molecular biology of prostate intraepithelial neoplasia. Prostate 29:117-134, 1996.
98. Cunningham JM, Shan A, Wick MJ, et al: Allelic imbalance and microsatellite instability in prostatic adenocarcinoma. Cancer Res 56:4475-4482, 1996.
99. Suzuki H, Freije D, Nusskern DR, et al: Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues. Cancer Res 58:204-209, 1998.
100. Ueda T, Komiya A, Emi M, et al: Allelic losses on 18q are associate with progression and metastasis in human prostate cancer. Genes Chromosomes Cancer 20:140-147, 1997.
101. Stapleton AM, Timme TL, Gousse AE, et al: Primary human prostate cancer cell harboring p53 metastasis p53 mutations are clonally expanded in metastasis. Clin Cancer Res 3:1389-1397, 1997.
102. Suzuki H, Komiya A, Aida S, et al: Microsatellite instability and other molecular abnormalities in human prostate cancer. Jpn J Cancer Res 86:956-961, 1995.
103. Egawa S, Uchida T, Suyama K, Wang C, et al: Genomic instability of microsatellite repeats in prostate cancer: relationship to clinicopathological variables. Cancer Res 86:956-961, 1995.
104. Watnabe M, Imai H, Shiraishi T, et al: Microsatellite instability in human prostate cancer. Br J Cancer 72:562-564, 1995.
105. Roylance R, Spurr N, Sheer D: The genetic analysis of prostate carcinomas. Semin Cancer Biol 8:37-44, 1997.
106. MacGrogan D, Bookstein R: Tumor suppressor genes in prostate cancer. Semin Cancer Biol 8:11-19, 1997.
107. Cairns P, Okami K, Halachmi S, et al: Frequent inactivation of PTEN/MMAC1 in primary prostate cancer. Cancer Res 57: 4997-5000, 1997.
108. Sadsivan R, Morgan R, Jennings S, et al: Overexpression of HER-2/neu may be an indicator of poor prognosis in prostate cancer. J Urol 150:126-131, 1993.
109. Kuczyk MA, Serth J, Bokemeyer C, et al: The MXI1 tumor suppressor gene is not mutated in primary prostate cancer. Oncol Rep 5:213-216, 1998.
110. Trybus TM, Burgess AC, Wojno KJ, et al: Distinct areas of allelic loss on chromosome regions 10p and 10q in human prostate cancer. Cancer Res 56:2263-2267, 1996.
111. Ford S, Gray IC, Spurr NK: Rearrangement of the long arm of chromosome 10 in the prostate adenocarcinoma cell line LNCaP. Cancer Genet Cytogenet 102:6-10, 1998.
112. Li C, Larsson C, Futreal A, et al: Identification of two distinct regions on chromosome 13 in prostate cancer. Oncogene 29: 481-487, 1998.
113. Jenkins R, Takahashi S, DeLacey K, et al: Prognostic significance of allelic imbalance of chromosome arms 7q, 8p, 16q, and 18q in stage T3NOMO prostate cancer. Genes Chromosomes Cancer 21:131-143, 1998.
114. Ford S, Gray IC, Spurr NK: Rearrangement of the long arm of chromosome 10 in the prostate adenocarcinoma cell line LNCap. Cancer Genet Cytogenet 102:6-11, 1998.
115. Cheng L, Song SY, Pretlow TG, et al: Evidence of independent origin of multiple tumors from patients with prostate cancer. J Natl Cancer Inst 90:233-237, 1998.
116. Elles RA, Durocher F, Edwards S, et al: Linkage analysis of chromosome 1q markers in 136 prostate cancer families. Am J Hum Genet 62:653-658, 1998.
117. Carter BS, Beaty TH Steinberg GD, et al: Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci USA 89:3367-3371, 1992.
118. Gronberg H, Damber L, Damber JE: Familial prostate cancer in Sweden. Cancer 77:138-143, 1996.
119. Berthon P, Valeri A, Cohen-Akenine A, et al: Predisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2-43. Am J Hum Genet 62:1416-1424, 1998.
120. Deubler DA, Williams BJ, Zhu XL, et al: Allelic loss detected on chromosomes 8, 10, and 17 by fluorescence in situ hybridization using single-copy P1 probes on isolated nuclei from paraffin embedded prostate tumors. Am J Pathol 150:841-850, 1997.
121. Schaid DJ, McDonnell SK, Blute ML, et al: Evidence for autosomal dominant inheritance of prostate cancer. Am J Hum Genet 62:1425-1438, 1998.
122. Monroe KR, Yu MC, Kolonel LN, et al: Evidence of an X-linked or recessive genetic component to prostate cancer risk. Nat Med 1:827-832, 1995.
123. Macintosh CA, Stower M, Reid N, et al: Precise microdissection of human prostate cancers reveals genotypic heterogeneity. Cancer Res 58:23-28, 1998.
124. Cannon-Albright LA, Eeles RA: Progress in prostate cancer. Nat Genet 9:336-337, 1995.